New Lasker Lessons in Leadership Workshop Discusses Best Strategies For Communicating the Value of Complex Medical Research
Postgraduate medical research students learn how to explain the benefits of their work to multiple audiences
PRINCETON, NJ – Jan. 21, 2016 – WIRB-Copernicus Group® (WCG), the world’s largest provider of regulatory and ethical review services and software to support clinical research, and Certara®, the global biosimulation technology-enabled drug development company, today announced their support of the third “Lasker Lessons in Leadership” career-oriented workshop for postgraduate medical research students, which was held on Jan. 14 at the National Institutes of Health (NIH) Main Campus in Bethesda, MD. This workshop will help participants to discuss their research effectively with peers, researchers in other fields, and lay audiences.
This student education program, which was developed by the Albert and Mary Lasker Foundation in collaboration with the International Biomedical Research Alliance and the NIH Oxford-Cambridge Scholars Program, is aimed at helping the next generation of physicians and scientists to develop the leadership skills necessary to advance scientific discovery.
“WCG is proud to support the talented medical researchers who will one day cure many intractable diseases,” commented WCG Chairman and Chief Executive Officer (CEO) Donald A. Deieso, PhD. “Through the Lasker Lessons in Leadership series, we are able to give these postgraduate students the business and communications skills they will need to optimize their careers in medical research.”
“Certara’s mission is to help get safer, more effective drugs into the hands of patients who need them as quickly as possible,” said Certara CEO Edmundo Muniz, MD, PhD. “To meet this goal, we need to maximize medical research students’ abilities not only to make medical breakthroughs, but also communicate their significance effectively to the requisite audiences. We are delighted to support the Lasker Lessons in Leadership efforts in this area.”
Dr. Linda Fried, dean of the Mailman School of Public Health at Columbia University, gave the keynote address. Dr. Fried is a pioneer in the science of healthy aging, helping to define frailty as a medical condition, examining its causes and ways to prevent it. She is also the designer and co-founder of Experience Corps, a scientifically-designed, community-based program in 19 cities that sends senior volunteers to work in public schools. Dr. Fried demonstrated via clinical trial that this approach helps to prevent physical disability and cognitive decline among older adults, while also raising literacy among the children.
Before becoming dean of the Mailman School, Dr. Fried founded the Johns Hopkins Center on Aging and Health, and directed the Program on the Epidemiology and Biostatistics of Aging and the Division of Geriatric Medicine and Gerontology. She received the Alliance for Aging Research’s 2011 Silver Innovator Award, its 2012 Silver Scholar Award, and Foundation IPSEN’s 2012 Longevity Prize, in recognition of her contributions to research on aging. Dr. Fried was named a Living Legend in Medicine by the U.S. Congress in 2004. In 2012, she was recognized by the New York Times as one of 15 world leaders in science. In 2014, Thomson Reuters named her “one of the year’s most influential scientific minds.” She was also appointed The 2015 Ralph and Lorraine Lubin Distinguished Visiting Professor in the Department of Healthcare Policy and Research at Weill Cornell Medical Center.
Lasker Lessons in Leadership attendees also participated in a mentor panel discussion with Linda Huynh, PhD, Tom Wynn, PhD, and Michele Hogan, PhD. Dr. Huynh is a scientific writer/editor in the Public Communications Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the NIH. Dr. Wynn is Chief, Immunopathogenesis Section, Laboratory of Parasitic Disease, NIAID at the NIH and Scientific Director of the NIH Oxford-Cambridge Scholars Program. Dr. Hogan is executive director of the American Association of Immunologists.
This student education program, which was developed by the Albert and Mary Lasker Foundation in collaboration with the International Biomedical Research Alliance and the NIH Oxford-Cambridge Scholars Program, is co-sponsored by WCG and Certara.
Lasker Foundation President Claire Pomeroy, MD, MBA, said, “We appreciate the opportunity to work with NIH and the International Biomedical Research Alliance to provide these talented young scholars with the necessary tools and training to become future leaders in science and medicine.”
The NIH Oxford-Cambridge Scholars Program was created in 2001, through collaboration between the NIH and Oxford and Cambridge Universities, to revolutionize the way in which the most talented biomedical PhD and MD/PhD students in the United States and the European Union are taught. These students receive accelerated training, work on collaborative projects that address critical biomedical research problems, and graduate earlier than in traditional programs with a PhD degree from either Oxford or Cambridge University. They spend an equal amount of time with a mentor in a laboratory at either Oxford or Cambridge University and an NIH Intramural Laboratory.
Dr. Linda Fried’s keynote address and the panel discussion videocast is archived at http://videocast.nih.gov/PastEvents.asp?c=0&s=1.
For additional information regarding the Lasker Lessons in Leadership series, please contact Randi Balletta at email@example.com.
Further information about the NIH Oxford-Cambridge Scholars Program can be found at http://oxcam.gpp.nih.gov.
About WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world’s largest provider of regulatory and ethical solutions for clinical research. The company provides Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) reviews, and Human Research Protection (HRP), Good Clinical Practice (GCP) and Biosafety consulting services. Its technology offerings include IRB workflow management solutions (IRBNet), clinical trial management software for sponsors and contract research organizations (ePharmaSolutions), and Part-11 compliant online learning solutions for research professionals (WCG Academy).
The pioneer of independent ethical oversight, WCG continues to drive progress in the clinical research space. WCG empowers clients to accelerate life-saving advancements, while ensuring that the risks of progress never outweigh the value of human life.
For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical.
Certara is a global biosimulation and regulatory writing company, committed to optimizing drug development decisions. Its clients include hundreds of international biopharmaceutical companies, leading academic institutions, and key regulatory agencies. Certara’s solutions, which span drug discovery through patient care, increase the probability of regulatory and commercial success by using the most scientifically-advanced modeling and simulation technologies and regulatory strategies. For more information, visit www.certara.com.
About the Albert and Mary Lasker Foundation
Founded in 1942, the Albert and Mary Lasker Foundation seeks to improve health by accelerating support for medical research through recognition of scientific excellence, public education, and advocacy. For much of the last Century, the Foundation was led by Mary Lasker, who was America’s most prominent citizen-activist for public investment in medical research. She is widely credited with motivating the White House and Congress to greatly expand federal funding for medical research, particularly through the National Institutes of Health. For more information, please visit: http://www.laskerfoundation.org.
About the International Biomedical Research Alliance
The Alliance’s mission is to support the NIH Oxford-Cambridge Scholars Program and associated global PhD and MD/PhD training programs based in the Intramural Research Program of the NIH, America’s largest biomedical research organization. Its goal is to assure the financial viability and scientific excellence of the Scholars’ program by supplementing government funding. The Alliance supports program events and scholarships designed to enrich the program and broaden the perspectives of its highly selective students as they train to become the next leaders in biomedical research. It was created in 2005 as a 501(c)(3) non-profit organization. For more information, please visit http://biomedalliance.org.